A detailed history of Clear Harbor Asset Management, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 57,804 shares of CNTX stock, worth $54,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,804
Previous 36,000 60.57%
Holding current value
$54,335
Previous $70,000 18.57%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$0.98 - $2.35 $21,367 - $51,239
21,804 Added 60.57%
57,804 $57,000
Q2 2023

Jul 21, 2023

BUY
$0.48 - $1.6 $17,280 - $57,600
36,000 New
36,000 $57,000

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $15M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.